Fundraising Fox

Jounce Therapeutics

Cambridge, US · Founded 2012 · Delaware corporation · 2 known investors

jouncetx.com ↗
Biotech

Founders & leadership

RT
Robert TepperDirector
KC
Kim C. DrapkinExecutive Officer
AL
Anna L. BarryExecutive Officer
RM
Richard MurrayExecutive Officer, Director
CP
Cary PfefferDirector
RK
Robert KamenDirector

Investors · 2

Nextech InvestZurich · $648K – $3.2M
Third Rock VenturesreportedBoston · $100K – $5Mvia Robert Kamen · board

Reported raises · per SEC filings

Form D private placements
▶$35MraisedOct 2020 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Luis A. Diaz, Jr.Director
  • Duncan HiggonsDirector
  • Robert IannoneDirector
  • Robert KamenDirector
  • Cary PfefferDirector
  • Robert TepperDirector
  • Perry KarsenDirector
  • Elizabeth G. TrehuExecutive Officer
  • Hugh M. ColeExecutive Officer
  • Kimberlee C. DrapkinExecutive Officer
  • Richard MurrayExecutive Officer, Director
  • Barbara DuncanDirector
Offering amount
$35M
Amount sold
$35M
First sale
Oct 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$56MraisedApr 2015 · 14 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert TepperDirector
  • Kim C. DrapkinExecutive Officer
  • Anna L. BarryExecutive Officer
  • Richard MurrayExecutive Officer, Director
  • Cary G. PfefferDirector
  • Robert KamenDirector
Offering amount
$56M
Amount sold
$56M
First sale
Apr 2015
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.